Clover Health CFO Peter Kuipers discussed the benefit expense ratio with UBS analysts on August 13, 2025.
7 reports, 2 independent
Updated Sep 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 7
- Developments
- 2
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Clover Health CFO Peter Kuipers discussed the benefit expense ratio with UBS analysts on August 13, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Clover Health CFO addressed UBS analyst questions regarding the benefit expense ratio.1 source
- Clover Health CFO Peter Kuipers was questioned by UBS analysts about medical cost trends and competitive landscape.
Keep exploring
The entities involved
-
Clover Health
U.S. healthcare company
-
UBS
Swiss multinational investment bank and financial services company
-
Peter Kuipers
photographer
Nothing else this week.
Coverage
Newest first; wire copies grouped- StockStoryThe Top 5 Analyst Questions From Clover Health’s Q2 Earnings Call Clover Health’s second quarter was marked by solid revenue growth and increased membership, but the market reacted negatively, likely
- GlobeNewswireClover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-year Second quarter 2025 Total r
- Unknown outlet